The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Treating insomnia: Current and investigational pharmacological approaches
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Van Dongen, H. P. A., Maislin, G., Mullington, J. M., & Dinges, D. F. (2003) · Sleep · doi:10.1093/sleep/26.2.117 · Cited by 3,173
Hypothalamic regulation of sleep and circadian rhythms
Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804
Neurocognitive consequences of sleep deprivation
Goel, N., Rao, H., Durmer, J., & Dinges, D. (2009) · Seminars in Neurology · doi:10.1055/s-0029-1237117 · Cited by 2,154
Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat
Moore, R. Y., & Eichler, V. B. (1972) · Brain Research · doi:10.1016/0006-8993(72)90054-6 · Cited by 2,135
Huber, R., Felice Ghilardi, M., Massimini, M., & Tononi, G. (2004) · Nature · doi:10.1038/nature02663 · Cited by 1,854
Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults
Breslau, N., Roth, T., Rosenthal, L., & Andreski, P. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00188-3 · Cited by 1,831
Neurocognitive Consequences of Sleep Deprivation
Durmer, J. S., & Dinges, D. F. (2005) · Seminars in Neurology · doi:10.1055/s-2005-867080 · Cited by 1,473
Dijk, D., & Czeisler, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03526.1995 · Cited by 1,356
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161
Vgontzas, A. N., Bixler, E. O., Lin, H.-M., Prolo, P., Mastorakos, G., Vela-Bueno, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7778 · Cited by 884
Research works printed but not linked: 153
- Åkerstedt, 1977, Psychophysiological circadian rhythms in women during 72 h of sleep deprivation, Waking Sleeping, 1, 387
- Amici, 2004, A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat, Brain Res, 996, 9, 10.1016/j.brainres.2003.09.026 · DOI
- Ancoli-Israel, 1999, Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects, Prim Care Companion J Clin Psychiatry, 1, 114, 10.4088/PCC.v01n0404 · DOI
- Arendt, 1997, Treatment of circadian rhythm disorders, Chronobiol Int, 14, 185, 10.3109/07420529709001155 · DOI
- Arendt, 1995, Melatonin and adjustment to phase shift, J Sleep Res, 4, 74, 10.1111/j.1365-2869.1995.tb00232.x · DOI
- Ator, 2000, Zaleplon and triazolam: drug discrimination, plasma levels, and self administration in baboons, Drug Alcohol Depend, 24, 55, 10.1016/S0376-8716(00)00123-X · DOI · Paper page
- Ator, 1986, Discriminative stimulus effects of atypical anxiolytics in baboons and rats, J Pharmacol Exp Ther, 237, 393
- Baker, 2005, Persistence of sleep–temperature coupling after suprachiasmatic nuclei lesions in rats, Am J Physiol Regul Integr Comp Physiol, 289, R827, 10.1152/ajpregu.00093.2005 · DOI
- Bateson, 2004, The benzodiazepine site of the GABAA receptor: an old target with new potential?, Sleep Med, 5, 9, 10.1016/S1389-9457(04)90002-0 · DOI
- Belelli, 2005, Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics, J Neurosci, 25, 11513, 10.1523/JNEUROSCI.2679-05.2005 · DOI · Paper page
- Benke, 1996, GABAA receptor subtypes differentiated by their gamma-subunit variants: prevalence, pharmacology and subunit architecture, Neuropharmacology, 35, 1413, 10.1016/S0028-3908(96)00068-8 · DOI
- Bianchi, 1990, Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena, Int Clin Psychopharmacol, 5, 139
- Bispink, 1990, Influence of melatonin on the sleep-independent component of prolactin secretion, J Pineal Res, 8, 97, 10.1111/j.1600-079X.1990.tb00669.x · DOI
- Blin, 2005, Zolpidem modified-release 12.5 mg has no residual effects on psychomotor performance and cognitive function in healthy adult subjects, Sleep, 28, A246
- Borbely, 1982, A two process model of sleep regulation, Hum Neurobiol, 1, 195
- Borbely, 1999, Sleep homeostasis and models of sleep regulation, J Biol Rhythms, 14, 557
- Borbely, 1985, Effect of benzodiazepine hypnotics on all-night sleep EEG spectra, Hum Neurobiol, 4, 189
- Brown, 2002, Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors, Br J Pharmacol, 136, 965, 10.1038/sj.bjp.0704795 · DOI · Paper page
- Brunello, 2000, Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment, Neuropsychobiology, 42, 107, 10.1159/000026680 · DOI
- Brunner, 1991, Effect of zolpidem on sleep and sleep EEG spectra in healthy young men, Psychopharmacology (Berlin), 104, 1, 10.1007/BF02244546 · DOI
- Brunner, 1993, Repeated partial sleep deprivation progressively changes in EEG during sleep and wakefulness, Sleep, 16, 100, 10.1093/sleep/16.2.100 · DOI · Paper page
- Cajochen, 1997, Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis, Am J Physiol, 272, R1189
- Chou, 2002, Afferents to the ventrolateral preoptic nucleus, J Neurosci, 22, 977, 10.1523/JNEUROSCI.22-03-00977.2002 · DOI · Paper page
- Danjou, 1999, A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening, Br J Clin Pharmacol, 48, 367, 10.1046/j.1365-2125.1999.00024.x · DOI
- Davies, 2000, Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors, Mol Pharmacol, 58, 756, 10.1124/mol.58.4.756 · DOI
- Deacon, 1995, Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans, Brain Res, 688, 77, 10.1016/0006-8993(95)96872-I · DOI · Paper page
- Deacon, 1996, Adapting to phase shifts: II. Effects of melatonin and conflicting light treatment, Physiol Behavior, 59, 675, 10.1016/0031-9384(95)02148-5 · DOI
- Deacon, 1994, Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans, Neurosci Lett, 178, 32, 10.1016/0304-3940(94)90282-8 · DOI
- Dijk, 1997, Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG, J Biol Rhythms, 12, 627, 10.1177/074873049701200618 · DOI · Paper page
- Dijk, 1994, Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans, Neurosci Lett, 166, 63, 10.1016/0304-3940(94)90841-9 · DOI · Paper page
- Dijk, 1989, All night spectral analysis of EEG sleep in young adult and middle-aged male subjects, Neurobiol Aging, 10, 677, 10.1016/0197-4580(89)90004-3 · DOI · Paper page
- Dijk, 1992, Circadian and sleep/wake dependent aspects of subjective alertness and cognitive performance, J Sleep Res, 1, 112, 10.1111/j.1365-2869.1992.tb00021.x · DOI · Paper page
- Dijk, 1999, Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms, J Physiol, 516, 611, 10.1111/j.1469-7793.1999.0611v.x · DOI · Paper page
- Dooley, 2000, Zaleplon: a review of its use in the treatment of insomnia, Drugs, 60, 413, 10.2165/00003495-200060020-00014 · DOI · Paper page
- Drake, 2003, Insomnia causes, consequences, and therapeutics: an overview, Depress Anxiety, 18, 163, 10.1002/da.10151 · DOI · Paper page
- Drake, 2004, Vulnerability to stress-related sleep disturbance and hyperarousal, Sleep, 27, 285, 10.1093/sleep/27.2.285 · DOI · Paper page
- Drosopoulos, 2005, Sleep enhances explicit recollection in recognition memory, Learn Mem, 12, 44, 10.1101/lm.83805 · DOI · Paper page
- Drover, 2004, Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone, Clin Pharmacokinet, 43, 227, 10.2165/00003088-200443040-00002 · DOI · Paper page
- Ebert, 1994, Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations, Mol Pharmacol, 46, 957
- Elie, 1999, Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group, J Clin Psychiatry, 60, 536, 10.4088/JCP.v60n0806 · DOI · Paper page
- Erman, 2001, Sleep architecture and its relationship to insomnia, J Clin Psychiatry, 62, 9
- Erman, 2006, An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia, Sleep Med, 7, 17, 10.1016/j.sleep.2005.09.004 · DOI · Paper page
- Faulhaber, 1997, The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans, Psychopharmacology (Berlin), 130, 285, 10.1007/s002130050241 · DOI
- Feinberg, 2000, Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications, J Psychiatr Res, 34, 423, 10.1016/S0022-3956(00)00038-8 · DOI
- Foster, 2004, In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, J Pharmacol Exp Ther, 311, 547, 10.1124/jpet.103.063487 · DOI
- Gaudreau, 2001, Age-related modifications of NREM sleep EEG: from childhood to middle age, J Sleep Res, 10, 165, 10.1046/j.1365-2869.2001.00252.x · DOI · Paper page
- Gaus, 2002, Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species, Neuroscience, 115, 285, 10.1016/S0306-4522(02)00308-1 · DOI · Paper page
- Griffiths, 1991, Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons, Psychopharmacology (Berlin), 103, 154, 10.1007/BF02244196 · DOI
- Griffiths, 2005, Ramelteon and triazolam in humans: behavioral effects and abuse potential, Sleep, 289, A44
- Hadingham, 1995, Expression and pharmacology of human GABAA receptors containing gamma 3 subunits, Eur J Pharmacol, 291, 301, 10.1016/0922-4106(95)90070-5 · DOI
- Hajak, 1999, A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience, Drug Saf, 21, 457, 10.2165/00002018-199921060-00003 · DOI · Paper page
- Hall, 2000, Symptoms of stress and depression as correlates of sleep in primary insomnia, Pyschosom Res, 62, 227
- Hansen, 2001, Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions, Br J Pharmacol, 133, 539, 10.1038/sj.bjp.0704121 · doi:10.1038/sj.bjp.0704121
- Hindmarch, 2001, Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening, Hum Psychopharmacol, 16, 159, 10.1002/hup.282 · DOI
- Hindmarch, 2005, Zolpidem modified-release significantly reduces latency to persistent sleep 4 and 5 hours post dose compared with standard zolpidem in a model assessing the return to sleep following nocturnal awakening, Sleep, 28, A245
- Hirai, 2005, Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats, J Biol Rhythms, 20, 27, 10.1177/0748730404269890 · DOI
- Hirshkowitz, 2004, Normal human sleep: An overview, Med Clin North Am, 88, 551, 10.1016/j.mcna.2004.01.001 · DOI · Paper page
- Jia, 2005, An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons, J Neurophysiol, 94, 4491, 10.1152/jn.00421.2005 · DOI · Paper page
- Jochelson, 2004, Efficacy of indiplon in inducing and maintaining sleep in patients with chronic sleep maintenance insomnia, Sleep, 27, A262
- Jones, 2000, Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner, Cancer Lett, 151, 133, 10.1016/S0304-3835(99)00394-8 · DOI
- Kantor, 2002, Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift, Brain Res, 943, 105, 10.1016/S0006-8993(02)02698-7 · DOI
- Katz, 2002, The relationship between insomnia and health-related quality of life in patients with chronic illness, J Fam Pract, 51, 229
- Krystal, 2003, Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia, Sleep, 26, 793, 10.1093/sleep/26.7.793 · DOI · Paper page
- Lancel, 1997, The GABA(A) agonist THIP increases non-REM sleep and enhances non-REM sleep-specific delta activity in the rat during the dark period, Sleep, 20, 1099, 10.1093/sleep/20.12.1099 · DOI
- Lancel, 2000, Gamma-aminobutyric acid(A) (GABA(A)) agonist 4,5,6, 7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol persistently increases sleep maintenance and intensity during chronic administration to rats, J Pharmacol Exp Ther, 293, 1080, 10.1016/S0022-3565(24)39335-8 · DOI
- Lancel, 1996, Role of GABAA receptors in sleep regulation. Differential effects of muscimol and midazolam on sleep in rats, Neuropsychopharmacology, 15, 63, 10.1016/0893-133X(95)00157-9 · DOI
- Lancel, 2001, Effect of the GABAA agonist gaboxadol on nocturnal sleep and hormone secretion in healthy elderly subjects, Am J Physiol Endocrinol Metab, 281, 130, 10.1152/ajpendo.2001.281.1.E130 · DOI
- Lancel, 2005, The GABAA agonist gaboxadol improves subjective and objective sleep quality in elderly subjects, Sleep, 28, A234
- Lankford, 2005, Efficacy and tolerability of indiplon-MR in elderly patients with chronic insomnia: results of a double-blind, placebo-controlled, 2-week trial, Sleep, 28, A230
- Lavie, 1986, Differential effects of awakening from REM and NONREM sleep on dichotic listening performance as a function of handedness, Int J Neurosci, 30, 37, 10.3109/00207458608985653 · doi:10.3109/00207458608985653
- Lavie, 1997, Melatonin: role in gating nocturnal rise in sleep propensity, J Biol Rhythms, 12, 657, 10.1177/074873049701200622 · DOI · Paper page
- Legangneux, 2005, Zolpidem modified-release 6.25 mg and double dose 12.5 mg have no residual effects on central nervous system integrative capacity, sensorimotor and psychomotor performance, and immediate and delayed memory recall in healthy elderly subjects, Sleep, 28, A245
- Leger, 2005, An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition, Curr Med Res Opin, 21, 1785, 10.1185/030079905X65637 · DOI · Paper page
- Leger, 2006, Professional correlates of insomnia, Sleep, 29, 171
- Lerchl, 1995, Circadian and ultradian variations of pituitary and pineal hormones in normal men: evidence for a link between melatonin, gonadotropin, and prolactin secretion, J Pineal Res, 18, 41, 10.1111/j.1600-079X.1995.tb00138.x · DOI
- Lu, 2000, Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep, J Neurosci, 20, 3830, 10.1523/JNEUROSCI.20-10-03830.2000 · DOI · Paper page
- Lu, 2002, Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep, J Neurosci, 22, 4568, 10.1523/JNEUROSCI.22-11-04568.2002 · DOI · Paper page
- Lund, 2005, The pharmacokinetic properties of gaboxadol, a new hypnotic, in young and elderly men, Sleep, 28, A48
- Luscher, 2004, Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses, Pharmacol Ther, 102, 195, 10.1016/j.pharmthera.2004.04.003 · DOI · Paper page
- Lustberg, 2000, Depression and insomnia: questions of cause and effect, Sleep Med Rev, 4, 253, 10.1053/smrv.1999.0075 · DOI · Paper page
- Mathias, 2001, The GABA(A) agonist gaboxadol improves the quality of post-nap sleep, Psychopharmacology (Berlin), 157, 299, 10.1007/s002130100819 · DOI
- Mathias, 2001, The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects, Neurobiol Aging, 22, 247, 10.1016/S0197-4580(00)00232-3 · DOI
- Mathias, 2004, Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects, Neuropsychopharmacology, 30, 833, 10.1038/sj.npp.1300641 · DOI
- McKernan, 1996, Which GABAA-receptor subtypes really occur in the brain?, Trends Neurosci, 19, 139, 10.1016/S0166-2236(96)80023-3 · DOI · Paper page
- McKernan, 2000, Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype, Nat Neurosci, 3, 587, 10.1038/75761 · DOI · Paper page
- McMahon, 2005, Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys, Psychopharmacology (Berlin), 178, 400, 10.1007/s00213-004-2022-4 · DOI
- Melton, 2005, Eszopiclone for insomnia, Ann Pharmacother, 39, 1659, 10.1345/aph.1G179 · DOI
- Merica, 1998, Spectral characteristics of sleep EEG in chronic insomnia, Eur J Neurosci, 10, 1826, 10.1046/j.1460-9568.1998.00189.x · DOI · Paper page
- Mignot, 2002, Sleeping with the hypothalamus: Emerging therapeutic targets for sleep disorders, Nat Neurosci 5 Suppl, 1071, 10.1038/nn944 · DOI · Paper page
- Millan, 2003, The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways, J Pharmacol Exp Ther, 306, 954, 10.1124/jpet.103.051797 · DOI · Paper page
- Mitler, 2000, Nonselective and selective benzodiazepine receptor agonists-where are we today?, Sleep, 23, 39
- Miyamoto, 2004, The sleep-promoting action of ramelteon (TAK-375) in freely moving cats, Sleep, 27, 1319, 10.1093/sleep/27.7.1319 · DOI
- Mody, 2004, Diversity of inhibitory neurotransmission through GABA(A) receptors, Trends Neurosci, 27, 569, 10.1016/j.tins.2004.07.002 · DOI · Paper page
- Mohler, 2002, A new benzodiazepine pharmacology, J Pharmacol Exp Ther, 300, 2, 10.1124/jpet.300.1.2 · DOI · Paper page
- Neubauer, 2005, Indiplon: the development of a new hypnotic, Expert Opin Investig Drugs, 14, 1269, 10.1517/13543784.14.10.1269 · DOI
- Nusser, 1998, Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells, J Neurosci, 18, 1693, 10.1523/JNEUROSCI.18-05-01693.1998 · DOI · Paper page
- Patat, 2001, Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent, Hum Psychopharmacol, 16, 369, 10.1002/hup.310 · DOI
- Perlis, 2001, Beta EEG activity and insomnia, Sleep Med Rev, 5, 363, 10.1053/smrv.2001.0151 · DOI · Paper page
- Petroski, 2006, Indiplon is a high-affinity positive allosteric modulator with selectivity for α1 subunit containing GABAA receptors, J Pharmacol Exp Ther, 317, 369, 10.1124/jpet.105.096701 · DOI
- Puia, 2001, Glial-neuronal interactions: a crescendo in the degree of CNS complexity, Trends Pharmacol Sci, 22, 498, 10.1016/S0165-6147(00)01856-3 · doi:10.1016/s0165-6147(00)01856-3
- Rajaratnam, 2004, Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans, J Physiol, 561, 339, 10.1113/jphysiol.2004.073742 · DOI · Paper page
- Roehrs, 1994, Sedative, memory, and performance effects of hypnotics, Psychopharmacology (Berlin), 116, 130, 10.1007/BF02245054 · DOI
- Roehrs, 2005, Zolpidem modified-release objectivity and subjectively improves sleep maintenance and retains the characteristics of standard zolpidem on sleep initiation and duration in elderly patients with primary insomnia, Sleep, 28, A244
- Rogers, 2001, Neuroimmunologic aspects of sleep and sleep loss, Semin Clin Neuropsychiatry, 6, 295, 10.1053/scnp.2001.27907 · DOI
- Rogowski, 2002, NBI-34060 (a non-benzodiazepine sedative-hypnotic): lack of a pharmacokinetic gender effect, Sleep, 25, A415
- Roth, 1999, Melatonin promotes osteoblast differentiation and bone formation, J Biol Chem, 274, 22041, 10.1074/jbc.274.31.22041 · DOI · Paper page
- Roth, 2005, Efficacy and safety of indiplon-IR in adults with chronic insomnia characterized by prolonged nighttime awakenings with difficulty returning to sleep, Sleep, 28, A229
- Rush, 1999, Zaleplon and triazolam in humans: acute behavioral effects and abuse potential, Psychopharmacology (Berlin), 145, 39, 10.1007/s002130051030 · DOI
- Sanna, 2002, Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes, Eur J Pharmacol, 451, 103, 10.1016/S0014-2999(02)02191-X · DOI · Paper page
- Saper, 2001, The sleep switch: hypothalamic control of sleep and wakefulness, Trends Neurosci, 24, 726, 10.1016/S0166-2236(00)02002-6 · DOI · Paper page
- Saper, 2005, Homeostatic, circadian, and emotional regulation of sleep, J Comp Neurol, 493, 92, 10.1002/cne.20770 · DOI · Paper page
- Sateia, 2004, Insomnia, Lancet, 364, 1959, 10.1016/S0140-6736(04)17480-1 · DOI · Paper page
- Saxena, 1994, Assembly of GABAA receptor subunits: role of the delta subunit, J Neurosci, 14, 7077, 10.1523/JNEUROSCI.14-11-07077.1994 · DOI · Paper page
- Scharf, 1994, A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia, J Clin Psychiatry, 55, 192
- Schultz, 1981, Preliminary studies on the absorption, distribution, metabolism, and excretion of THIP in animal and man using 14C-labelled compound, Acta Pharmacol Toxicol (Copenh), 49, 116, 10.1111/j.1600-0773.1981.tb00879.x · doi:10.1111/j.1600-0773.1981.tb00879.x
- Seiden, 2005, Double-blind, placebo-controlled outpatient clinical trial of ramelteon for the treatment of chronic insomnia in an elderly population, Sleep, 28, A228
- Semyanov, 2004, Tonically active GABAA receptors: Modulating gain and maintaining the tone, Trends Neurosci, 27, 262, 10.1016/j.tins.2004.03.005 · DOI · Paper page
- Sharpley, 1994, Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors, Neuropharmacology, 33, 467, 10.1016/0028-3908(94)90077-9 · DOI
- Silber, 2005, Chronic insomnia, N Engl J Med, 353, 803, 10.1056/NEJMcp043762 · DOI
- Smith, 2001, Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux, Mol Pharmacol, 59, 1108, 10.1124/mol.59.5.1108 · DOI
- Staner, 2005, Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring, Psychopharmacology (Berlin), 181, 790, 10.1007/s00213-005-0082-8 · DOI
- Stepanski, 1988, Daytime alertness in patients with chronic insomnia compared with controls, Sleep, 11, 54, 10.1093/sleep/11.1.54 · DOI · Paper page
- Steriade, 2004, Slow-wave sleep: serotonin, neuronal plasticity, and seizures, Arch Ital Biol, 142, 359
- Stickgold, 1998, Sleep: off-line memory reprocessing, Trends Cogn Sci, 2, 484, 10.1016/S1364-6613(98)01258-3 · DOI · Paper page
- Storustovu, 2003, Gaboxadol: in vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity, Eur J Pharmacol, 467, 49, 10.1016/S0014-2999(03)01603-0 · DOI
- Storustovu, 2005, Pharmacological characterisation of agonists at d containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on absence of g2, J Pharmacol Exp Ther, 10.1124/jpet.105.092403 · DOI · Paper page
- Sullivan, 2004, Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor, J Pharmacol Exp Ther, 311, 537, 10.1124/jpet.104.071282 · DOI
- Terzano, 2003, New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon, Drug Saf, 26, 261, 10.2165/00002018-200326040-00004 · DOI · Paper page
- Terzolo, 1993, Evening administration of melatonin enhances the pulsatile secretion of prolactin but not of LH and TSH in normally cycling women, Clin Endocrinol, 39, 185, 10.1111/j.1365-2265.1993.tb01772.x · DOI
- Trachsel, 1990, Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule, Neuropsychopharmacology, 3, 11
- Tripodi, 2004, Pharmacological effects of melatonin on reproductive activity: experimental bioimplants with sustained-release polymeric systems, Clin Exp Obstet Gynecol, 31, 117
- Van, 2001, Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers, Psychopharmacology (Berlin), 154, 189, 10.1007/s002130000633 · DOI
- Van, 2001, Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus, Am J Physiol Regul Integr Comp Physiol, 280, R1582, 10.1152/ajpregu.2001.280.5.R1582 · DOI
- Van Dongen, 2003, Investigating the interaction between the homeostatic and circadian processes of sleep–wake regulation for the prediction of waking neurobehavioral performance, J Sleep Res, 12, 181, 10.1046/j.1365-2869.2003.00357.x · DOI · Paper page
- Varkevisser, 2005, Chronic insomnia and performance in a 24-h constant routine study, J Sleep Res, 14, 49, 10.1111/j.1365-2869.2004.00414.x · DOI
- Viola, 2002, Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers, Clin Neurophysiol, 113, 429, 10.1016/S1388-2457(02)00014-7 · DOI
- Voshaar, 2004, Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study1, Eur Neuropsychopharmacol, 14, 301, 10.1016/j.euroneuro.2003.09.007 · DOI
- Voss, 2003, Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance, Eur J Pharmacol, 482, 215, 10.1016/j.ejphar.2003.10.007 · DOI
- Wafford, 2005, GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence?, Curr Opin Pharmacol, 5, 1, 10.1016/j.coph.2004.08.006 · DOI
- Wafford, 1993, Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes, Mol Pharmacol, 43, 240
- Wagner, 2000, Non-benzodiazepines for the treatment of insomnia, Sleep Med Rev, 4, 551, 10.1053/smrv.2000.0126 · DOI
- Walker, 2005, A refined model of sleep and the time course of memory formation, Behav Brain Sci, 28, 51, 10.1017/S0140525X05000026 · DOI · Paper page
- Walsh, 2000, Eight weeks of non-nightly use of zolpidem for primary insomnia, Sleep, 23, 1087, 10.1093/sleep/23.8.1h · DOI · Paper page
- Walsh, 2000, A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia, Sleep Med, 1, 41, 10.1016/S1389-9457(99)00006-4 · DOI
- Walsh, 2004, Treatment of primary insomnia for five weeks with indiplon-IR, Sleep, 27, A259
- Whiting, 1999, Molecular and functional diversity of the expanding GABA-A receptor gene family, Ann N Y Acad Sci, 868, 645, 10.1111/j.1749-6632.1999.tb11341.x · DOI · Paper page
- World Health Organization Expert Committee on Drug Dependence. (2003). Thirty-third report, 915 World Health Organ Tech Rep Ser 915, pp. 1-26.
- Yous, 1992, Novel naphthalenic ligands with high affinity for the melatonin receptor, J Med Chem, 35, 1484, 10.1021/jm00086a018 · DOI · Paper page
- Yukuhiro, 2004, Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys, Brain Res, 1027, 59, 10.1016/j.brainres.2004.08.035 · DOI
- Zammit, 1999, Quality of life in people with insomnia, Sleep, 22, S379
- Zammit, 2005, Double-blind, placebo-controlled polysomnography and outpatient trial to evaluate the efficacy and safety of ramelteon in adult patients with chronic insomnia, Sleep, 28, A228
- Zeman, 2005, Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile, Life Sci, 76, 1795, 10.1016/j.lfs.2004.08.034 · DOI
- Zhdanova, 2004, Advances in the management of insomnia, Expert Opin Pharmacother, 5, 1573, 10.1517/14656566.5.7.1573 · DOI
Cited by
Control of sleep and wakefulness
Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E., & McCarley, R. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00032.2011 · Cited by 1,477
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
Fatigue Countermeasures in Aviation
Caldwell, J. A., Mallis, M. M., Caldwell, J. L., Paul, M. A., Miller, J. C., & Neri, D. F. (2009) · Aviation, Space, and Environmental Medicine · doi:10.3357/asem.2435.2009 · Cited by 295
Melatonin decreases delirium in elderly patients: A randomized, placebo‐controlled trial
Al‐Aama, T., Brymer, C., Gutmanis, I., Woolmore‐Goodwin, S. M., Esbaugh, J., & Dasgupta, M. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2582 · Cited by 290
Enna, S. J. (2007) · The Receptors · doi:10.1007/978-1-59745-465-0_1 · Cited by 266
Metadata
- Authors
- Ebert, B., Wafford, K. A., & Deacon, S.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 112
- Issue
- 3
- Pages
- 612-629
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1997416795
- Cited by
- 166
- References
- 33
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating insomnia: Current and investigational pharmacological approaches. https://app.cochat.ai/papers/10.1016/j.pharmthera.2005.04.014
- The paper
- Ebert, B., Wafford, K. A., & Deacon, S. (2006). Treating insomnia: Current and investigational pharmacological approaches. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2005.04.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.